Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients

This publication has 35 references indexed in Scilit:

• The Kuopio Atherosclerosis Prevention Study (KAPS): Effect of pravastatin treatment on lipids, oxidation resistance of lipoprotems, and atherosclerotic progression
  The American Journal of Cardiology, 1995
• Elevated levels of authentic plasma hydroperoxides in NIDDM
  Diabetes, 1995
• Plasma Oxidizability in Subjects With Normal Glucose Tolerance, Impaired Glucose Tolerance, and NIDDM
  Diabetes Care, 1995
• Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
• Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells
  Atherosclerosis, 1993
• Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
• Role of oxidative stress in development of complications in diabetes
  Diabetes, 1991
• Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
• CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
• A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
  Canadian Journal of Biochemistry and Physiology, 1959